Literature DB >> 15577004

[Hormone replacement therapy and osteoporosis].

Kazuhiro Takahashi1, Jun Kawagoe, Masahide Ohmichi, Hirohisa Kurachi.   

Abstract

Estrogen deficiency is one significant cause of accelerated bone loss in women during and after menopause. Postmenopausal osteoporosis is a major health problem, primarily because of the severe morbidity and mortality associated with osteoporotic fractures. The Women's Health Initiative Study (WHI) reported that hormone replacement therapy (HRT) prevented osteoporotic fractures. The risks and benefits of HRT are complex and require the individual assessment of each woman considering taking HRT. Use of HRT can be considered as a treatment option for osteoporosis but the risks and benefits should be discussed with each individual woman before starting treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15577004     DOI: CliCa0403436441

Source DB:  PubMed          Journal:  Clin Calcium        ISSN: 0917-5857


  2 in total

1.  Role of Sandhika: a polyherbal formulation on MC3T3-E1 osteoblast-like cells.

Authors:  Yamini B Tripathi; Pratibha Tripathi; Kiranmayi Korlagunta; Sheau Ching Chai; Brenda J Smith; Bahram H Arjmandi
Journal:  Inflammation       Date:  2008-02       Impact factor: 4.092

2.  A double-blind, placebo-controlled trial of Fennel (Foeniculum vulgare) on menopausal symptoms: A high placebo response

Authors:  Masumeh Ghazanfarpour; Mona Najaf Najafi; Nosrat Baharian Sharghi; Mahsa Sadat Mousavi; Masoudeh Babakhanian; Hassan Rakhshanded
Journal:  J Turk Ger Gynecol Assoc       Date:  2018-05-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.